Form 8-K FIBROGEN INC For: May 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
FibroGen (FGEN) Tops Q1 EPS by 11c
May 9, 2016 4:45 PM EDTFibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.45), $0.11 better than the analyst estimate of ($0.56).
At March 31, 2016, FibroGen had $309.9 million of cash, cash equivalents, investments, receivables and restricted cash
For earnings history and earnings-related data on FibroGen (FGEN) click here.
... More